Sort by
Refine Your Search
-
Thank you for your interest. Please note this posting is to recruit for on-going and future positions. Join the forefront of groundbreaking research at the Beckman Research Institute of City of Hope, where we're changing lives and making a real difference in the fight against cancer, diabetes,...
-
well as disease relapse in order to design novel inhibitors to intervene the malignancies; 3) collaborative analyses of myeloid cancers genomics using high-throughput single-cell technology. The group conducts
-
scientific papers and grants · Work with PI and other team members to perform experiments in vitro and in vivo · Utilize the following in vitro skills (not limited to but including): o
-
labs involved in cutting edge technology, research, and clinical immunotherapeutic programs. Dr. Lior Goldberg’s lab currently has an opening for a Postdoctoral Fellow who will develop chimeric antigen
-
. We are looking for a highly motivated candidate with a PhD and/or MD degree interested in using novel biological and computational methods with the aim of developing novel strategies to improve CAR T
-
, preventing, and curing diseases, shaping the future of medicine through cutting-edge research. The laboratory of Dr. Heather McGee, MD, PhD, Assistant Professor in the Departments of Radiation Oncology and
-
experiments, as indicated below: PhD with 1 – 2 years relevant surgical experience. DVM, MD with 0 – 1 year relevant surgical experience. City of Hope is an equal opportunity employer. To learn more about our
-
labs involved in cutting edge technology, research, and clinical immunotherapeutic programs. Dr. Lior Goldberg’s lab currently has an opening for a Postdoctoral Fellow who will develop chimeric antigen
-
. Human synthetic insulin, monoclonal antibodies and numerous breakthrough cancer drugs are based on technology developed at the institution. AccessHope™, a subsidiary launched in 2019 serves employers and
-
leukemogenesis as well as disease relapse in order to design novel inhibitors to intervene the malignancies · Collaborative analyses of myeloid cancers genomics using high-throughput single-cell technology